Polymer therapeutics: Polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities

Advances in Polymer Science

Volumn 192, Issue 1, 2006, Pages 1-8

  Duncan, Ruth ^a   Ringsdorf, Helmut ^b   Satchi Fainaro, Ronit ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748531659     PISSN: 00653195     EISSN: None     Source Type: Book Series    
DOI: 10.1007/12_037     Document Type: Review

References (28)

1. Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347-360
2. Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214-221
3. Dhal PK, Holmes-Farley SR, Mandeville WH, Neenan TX (2002) Polymeric drugs. In: Encyclopedia of Polymer Science and Technology, 3rd edn. Wiley, New York, pp 555-580
4. Duncan R (2003) Polymer-drug conjugates. In: Budman D, Calvert H, Rowinsky E (eds) Handbook of Anticancer Drug Development. Lippincott, Williams & Wilkins, Philadelphia, pp 239-260
5. Editorial. Nanomedicine: grounds for optimism. Lancet, pp 362, 673; (2004) NIH Roadmap for Nanomedicines, Willis RC (2004) Good things in small packages. Nanotech advances are producing mega-results in drug delivery. Modern Drug Discov p 30-36. European Science Foundation Policy Briefing (2005) ESF Scientific Forward Look on Nanomedicine 23 February 2005 (www.esf.org)
6. Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161-171
7. Gebelein CG, Carraher CE (1985) Bioactive polymeric systems. Plenum, New York
8. Ringsdorf H (1975) Structure and properties of pharmacologically active polymers. Polym J Sci Polymer Symp 51:135-153
9. Davis FF (2002) The origin of pegnology. Adv Drug Del Rev 54:457-458
10. Kakizawa Y, Kataoka K (2002) Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev 54:203
11. Wagner E (2004) Strategies to improve DNA polyplexes for in vivo gene transfer: will "artificial viruses" be the answer? Pharm Res 21:8-14
12. Ringsdorf H (2004) Hermann Staudinger and the future of polymer research: jubilees - beloved occasions for cultural piety. Angew Chem Int Ed 43:1064-1076
13. Morawetz H (1985) Polymers: the origins and the growth of a science. Wiley, New York
14. Lehn JM (1995) Supramolecular chemistry: concepts and perspectives. Wiley, New York
15. Watson JD, Crick FH (1953) Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171:737-8
16. Jatzkewitz H (1955) Peptamin (glycyl-L-leucyl-mescaline) bound to blood plasma expander (polyvinylpyrrolidone) as a new depot form of a biologically active primary amine (mescaline). Naturforsch Z 10b:27-31
17. Breslow DS (1976) Biologically active synthetic polymers. Pure Appl Chem 46:103-13 Seymour LW (1991) Synthetic polymers with intrinsic anticancer activity. J Bioact Comp Polymers 6:178-216
18. Regelson W (1986) Advances in intraperitoneal (intracavitary) administration of synthetic polymers for immunotherapy and chemotherapy. J Bioact Compat Polymers 1:84-106
19. Gros L, Ringsdorf H, Schupp H (1981) Polymeric antitumour agents on a molecular and cellular level. Angew Chem Int Ed 20:301-323
20. de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, van-Hoof F (1974) Lysosomotropic agents. Biochem Pharmacol 23:2495-2531
21. Duncan R (2003) Polymer-drug conjugates. In: Budman D, Calvert H, Rowinsky E (eds) Book of anticancer drug development. Lippincott, Williams & Wilkins, Philadelphia, pp 239-260
22. Duncan R (2005) N-(2-Hydroxypropyl)methacrylamide copolymer conjugates. In: Kwon GS (ed) Polymeric drug delivery systems. Dekker, New York, pp 1-92
23. Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Greene AK, Corfas G, Folkman J (2004) Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nature Med 10:255-261
24. Pack DW, Hoffman AS, Pun S, Stayton PS (2005) Design and development of polymers for gene delivery. Nature Rev Drug Discov 4:581-593
25. Duncan R, Kopecek J (1984) Soluble synthetic polymers as potential drug carriers. Adv Polymer Sci 57:51-101
26. Bader H, Dorn K, Hupfer B, Ringsdorf H (1985) Polymeric monolayers and liposomes as models for biomembranes. How to bridge the gap between polymer science and membrane biology? Adv Polymer Sci 64:1-62
27. Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nature Rev Drug Discov 4:145-160
28. Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. In: Florence AT (ed) Advanced drug delivery reviews special issue on dendrimers. in press